PULSE BIOSCIENCES, INC. (PLSE)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 500K 1M 1.5M FY20: 0 FY21: 1.4M FY22: 700K FY23: 0 FY24: 0 FY25: 350K FY20 FY21 FY22 FY23 FY24 FY25

Gross Profit Annual

-12M -8M -4M 0 4M 8M 12M FY20: 0 FY21: -550K FY22: -11.2M FY23: 0 FY24: 0 FY25: -189K FY20 FY21 FY22 FY23 FY24 FY25

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Annual

-90M -60M -30M 0 30M 60M 90M FY15: -4.5M FY16: -9.5M FY17: -25.6M FY18: -37.5M FY19: -48M FY20: -50M FY21: -63M FY22: -58.1M FY23: -43.6M FY24: -56.3M FY25: -76.9M FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Net Income Annual

-75M -50M -25M 0 25M 50M 75M FY15: -2.8M FY16: -9.5M FY17: -25.6M FY18: -37.5M FY19: -47M FY20: -49.9M FY21: -63.7M FY22: -58.5M FY23: -42.2M FY24: -53.6M FY25: -72.8M FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Cost of Revenue Annual

0 5M 10M 15M FY16: 500K FY17: 800K FY18: 600K FY19: 600K FY20: 0 FY21: 2M FY22: 11.9M FY23: 0 FY24: 0 FY25: 539K FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Operating Cash Flow Annual

-60M -40M -20M 0 20M 40M 60M FY15: -3.3M FY16: -8.1M FY17: -11.1M FY18: -23.9M FY19: -34.2M FY20: -35.4M FY21: -54.1M FY22: -47M FY23: -33M FY24: -36.3M FY25: -54.1M FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Free Cash Flow Annual

-60M -40M -20M 0 20M 40M 60M FY15: -3.4M FY16: -8.1M FY17: -13.6M FY18: -24.2M FY19: -34.8M FY20: -35.8M FY21: -54.5M FY22: -47.4M FY23: -33.2M FY24: -36.5M FY25: -54.4M FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 25M 50M 75M FY20: 23.2M FY21: 28M FY22: 33.9M FY23: 49.7M FY24: 58.4M FY25: 67.4M FY20 FY21 FY22 FY23 FY24 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-2.40 -1.60 -0.80 0.00 0.80 1.60 2.40 Q4 '15: -0.37 Q1 '16: -0.53 Q2 '16: -0.68 Q3 '16: -0.79 Q4 '16: -0.87 Q1 '17: -0.88 Q2 '17: -1.08 Q3 '17: -1.39 Q4 '17: -1.71 Q1 '18: -1.99 Q2 '18: -2.10 Q3 '18: -2.22 Q4 '18: -2.20 Q1 '19: -2.18 Q2 '19: -2.19 Q3 '19: -2.12 Q4 '19: -2.27 Q1 '20: -2.35 Q2 '20: -2.33 Q3 '20: -2.27 Q4 '20: -2.15 Q1 '21: -2.29 Q2 '21: -2.34 Q3 '21: -2.31 Q4 '21: -2.29 Q1 '22: -2.16 Q2 '22: -2.02 Q3 '22: -2.03 Q4 '22: -1.73 Q1 '23: -1.41 Q2 '23: -1.19 Q3 '23: -0.89 Q4 '23: -0.88 Q1 '24: -0.80 Q2 '24: -0.78 Q3 '24: -0.80 Q4 '24: -0.91 Q1 '25: -0.98 Q2 '25: -1.06 Q3 '25: -1.14 Q4 '25: -1.08 Q1 '26: -1.10 Q2 '26: -1.18 Q4 '15 Q2 '17 Q4 '18 Q2 '20 Q4 '21 Q2 '23 Q4 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.